Quartesian Surpasses 250 Studies Employing Medrio's EDC Platform
Quartesian Surpasses 250 Studies Employing Medrio's EDC Platform News provided by Share this article Share this article PRINCETON, N.J., May 4, 2021 /PRNewswire/ -- Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, announced today that they have deployed Medrio's cloud-based EDC platform for 265 clinical studies world-wide. Quartesian's partnership with Medrio began in 2009 and they were an early participant in the Medrio Partner Program providing expanded services to better support mutual sponsor and CRO customers. ...
Source: prnewswire.com